🇺🇸 FDA
Pipeline program

UB-312

UB-312-101

Phase 1 mab completed

Quick answer

UB-312 for Parkinson's Disease is a Phase 1 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Parkinson's Disease
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials